Insights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.
Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:
🔹Alex Lopez, Chief Commercial Officer – Ace Vision Group
🔹Houman Hamadi, MD, PhD, Co-Founder & Chief Medical Officer – Optigo Biotherapeutics
🔹Leanne Lavriola, DO, MBA, President & CEO – InnSight Technology
🔹Nir Katchinskiy, PhD, CEO & Co-Founder – PulseMedica
Resources:
Ace Vision Group: https://acevisiongroup.com/
Optigo Biotherapeutics: https://www.optigobio.com/
InnSight Technology: https://www.innsightech.com/
PulseMedica: https://www.pulsemedica.com/
Explore More Articles
Pathogenesis of Presbyopia: A New Understanding of an Age-Old Disease
FOR MOST OF HISTORY, PRESBYOPIA has been defined as a “normal” refractive error caused by age, with discussion limited to the loss of near vision beginning in our 40s. Because we have had no effective therapeutic interventions available, presbyopia has been accepted as a natural part of life and treated primarily by changing power at either …
read moreVIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreA New Paradigm Shift: Parts 1 and 2 (Pages 25-31)
DUE TO THE AGING OF THE population, most of our population will spend roughly half of their lives as presby-opes. The etiology of presby-opia has been poorly understood, and treatment options have failed to address the true issues with the disease, creating compro mises in vision that patients are eager to find a solution for, …
read more